Lenalidomide-d5
- CAS No.
- 1227162-34-6
- Chemical Name:
- Lenalidomide-d5
- Synonyms
- CC-5013-d5;1-Oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline-d5;3-(4-Amino-1,3-dihydro-1-oxo-2H-isoindol-2-yl)-2,6-piperidinedione-d5
- CBNumber:
- CB43070473
- Molecular Formula:
- C13H8D5N3O3
- Molecular Weight:
- 264.29142889
- MDL Number:
- MOL File:
- 1227162-34-6.mol
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302 | |||||||||
| Precautionary statements | P264-P270-P301+P312-P330-P501 | |||||||||
| NFPA 704 |
|
Lenalidomide-d5 price More Price(4)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 22370 | Lenalidomide-d5 ≥99% deuterated forms (d1-d5) | 1227162-34-6 | 500μg | $201 | 2024-03-01 | Buy |
| Cayman Chemical | 22370 | Lenalidomide-d5 ≥99% deuterated forms (d1-d5) | 1227162-34-6 | 1mg | $362 | 2024-03-01 | Buy |
| AK Scientific | 3538DG | 3-(7-Amino-3-oxo-1H-isoindol-2-yl)-3,4,4,5,5-pentadeuteriopiperidine-2,6-dione | 1227162-34-6 | 1mg | $500 | 2021-12-16 | Buy |
| aablocks | AA009JKU | Lenalidomide-d5 ≥99%deuteratedforms(d1- |
1227162-34-6 | 1mg | $422 | 2021-12-16 | Buy |
Lenalidomide-d5 Chemical Properties,Uses,Production
Biological Activity
Lenalidomide-d5 is intended for use as an internal standard for the quantification of lenalidomide by GC- or LC-MS. Lenalidomide is related to thalidomide and, at 10 μM, alters gene expression and cell viability in a range of cancer cell lines.1 It also induces proliferation and enhances the functional capacity of T lymphocytes, amplifying co-stimulatory signaling pathways.2 Lenalidomide is effective in hematologic cancers, including lymphomas and myelomas.3,4
References
1.Kim, K., An, S., Cha, H.J., et al.Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cellsOncol.Lett.5(2)588-596(2013) 2.McDaniel, J.M., Pinilla-Ibarz, J., and Epling-Burnette, P.K.Molecular action of lenalidomide in lymphocytes and hematologic malignanciesAdv. Hematol.513702(2012) 3.Latif, T., Chauhan, N., Khan, R., et al.Thalidomide and its analogues in the treatment of multiple myelomaExp.Hermatol.Oncol.1(1)27(2012) 4.Merli, M., Ferrario, A., Basilico, C., et al.Novel agents in indolent lymphomasTher.Adv.Hematol.4(2)133-148(2013)
Lenalidomide-d5 Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| SIMSON PHARMA LIMITED | +91-8291074273 | k.das@simsonpharma.com | India | 228 | 58 |
| Guangzhou PI PI Biotech Inc | +86-020-81716320 +86-13602409664 | Sales@pipitech.com | China | 3635 | 55 |
| Artis Biotech Co. Ltd. | 19138486554 18582380095 | sales@artisbio.com | China | 2804 | 58 |
| Hubei Yangxin Medical Technology Co., Ltd. | 15374522761 | 3003392093@qq.com | China | 8039 | 55 |
| Shenzhen SUNGENING Bio-Medical Co., Ltd. | 0755-28967200 13631290199 | wxf@sungening.com | China | 9507 | 60 |
| Nanjing Shizhou Biology Technology Co.,Ltd | 025-85560043 15850508050 | info@synzest.com | China | 9287 | 58 |
| PureChemland Co.,Ltd. | 19150123681 | 3848291069@qq.com | China | 3258 | 58 |
| Shanghai YuZn Pharm. Technology Co.,Ltd. | 15921286451; 15921286451 | 2010681527@qq.com | China | 5067 | 58 |
| Shanghai isotope chemical co.,ltd | 021-021-51600108 13062666369 | sales@chinaisotope.com | China | 4272 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 8740 | 58 |
View Lastest Price from Lenalidomide-d5 manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2023-05-27 | Lenalidomide-D5
1227162-34-6
|
US $0.00-0.00 / mg | 1mg | 96% | 50 mg | Simson Pharma limited |
-
- Lenalidomide-D5
1227162-34-6
- US $0.00-0.00 / mg
- 96%
- Simson Pharma limited
1227162-34-6(Lenalidomide-d5)Related Search:
1of4